Biotech Developer Divine Skin (DSKX) Announces New Brazilian Division to Exploit Latin American Markets

MIAMI BEACH, Fla., Oct. 4 /PRNewswire/ -- Divine Skin Inc. (OTC Bulletin Board: DSKX) announced the launch of its first Latin American subsidiary, DS Laboratories do Brasil Ltd., with a local office, resident pharmacist, and sales force now in place.

"We are thrilled to be launching in Brazil, the world's second largest cosmetics market after the United States," said Ezio Da Fonseca, president of DS Laboratories do Brasil. "The opportunities here are enormous."

"This is a major milestone in the meteoric growth of Divine Skin worldwide," added Daniel Khesin, founder and chief executive. "We expect Brazilian sales to be visible in 2010 figures and to contribute strongly in 2011 and beyond."

DS Laboratories, Divine Skin's first brand, begins Brazilian marketing operations with several level-1 cosmetics, including its Nia radiant-color shampoo and conditioner and Nirena pH-balanced feminine cleanser.

Brazil's regulatory authorities require blind 60-day efficiency tests for level-2 cosmetics such as the company's Oligo.DX advanced cellulite-reducing gel. In studies now concluding, this product has demonstrated an astounding 90-percent success rate.

Oligo.DX eliminates the unsightly appearance of dimpled fat, revealing smoother, firmer thighs, buttocks, and hips. The secret of its success is delivering active ingredients deeper, into lower layers of skin where cellulite forms. The formula features micropatch caffeine, proven in studies to penetrate deeper, persist longer, and dissolve lymphatic buildup better than the free form of the same ingredient. Proprietary Nanosome encapsulation assists further with absorption.

By the end of October, efficiency tests should wrap up for the company's Revita hair-growth-stimulating shampoo, which delivers ketoconazole, copper peptides, procyanidins, and additional compounds with powerful antioxidant properties, dihydrotestosterone inhibitors, and other hair-growth stimulants. Tests for the rest of DS Laboratories' line are expected to conclude by the end of this year.

In the next several months, DS Laboratories expects to roll out its leave-in hair-growth treatments, both with and without minoxidil.

Divine Skin's Brazilian strategy targets a rapidly expanding and ethnically diverse market of 201 million people, the fifth most populous country in the world.

One of the first emerging markets to recover after the recent downturn, Brazil's economy exceeds all other Latin American countries. It has a gross domestic product of $2 trillion (No. 10 in the world), median age of just 28.9 years, life expectancy of 72 years, and population growth rate of 1.2 percent per year.

By establishing new sales operations in Brazil, Divine Skin expects to minimize bureaucratic demands by the drug-control agency, Anvisa.

About Divine Skin

Divine Skin Inc. develops, markets, and distributes personal-care products through cosmetics wholesalers, online retailers, specialty outlets, spas, salons, and medical offices in more than 20 countries. Its brands include DS Laboratories, Sigma Skin, and Polaris Research.

DS Laboratories, the flagship brand, offers high-performance topical solutions for men and women to restore growth and radiance to hair; suppress dandruff and unwanted hair; control acne; maintain feminine hygiene; and reduce the appearance of cellulite, wrinkles, and double chins

(www.dslaboratories.com).

The Sigma Skin brand targets men and sells through upscale retailers like Bergdorf Goodman and Neiman Marcus in the United States, Saks Fifth Avenue in Mexico, and Harvey Nichols in the United Kingdom. Products are designed to reverse hair loss and other signs of aging

(www.sigmaskin.com).

Polaris Research makes high-potency minoxidil-based hair-growth formulas

(www.polarisresearch.co.uk).

Divine Skin's management believes the company has established itself as a leader in topical therapies, especially hair-growth, through aggressive pursuit of innovation and technology. Products employ comprehensive formulas with multiple methods of action against common skin conditions.

Many utilize proprietary encapsulation techniques for improved bioavailability.

SOURCE Divine Skin Inc.